Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
6.17
+0.22 (3.70%)
At close: Sep 4, 2026, 4:00 PM EDT
6.05
-0.12 (-1.94%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $908.22 million as of September 4, 2026. Its market cap has increased by 306.97% in one year.
Market Cap
908.22M
Enterprise Value
739.45M
1-Year Change
306.97%
Ranking
Category
Stock Price
$6.17
ChartMarket Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $908.22M, an increase of 323.50%. That is a compound annual growth rate of 14.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 908.22M | 178.49% |
| Dec 31, 2025 | 326.12M | 22.88% |
| Dec 31, 2024 | 265.41M | 256.83% |
| Dec 29, 2023 | 74.38M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.97% |
| Dec 31, 2021 | 890.25M | 220.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 954.37M |
| Olema Pharmaceuticals | 947.60M |
| Ardelyx | 933.21M |
| Annexon | 923.25M |
| Rigel Pharmaceuticals | 909.80M |
| Climb Bio | 902.32M |
| Crescent Biopharma | 893.69M |
| Theravance Biopharma | 886.77M |